Establishing a reference interval for serum anti-dsDNA antibody: A large Chinese Han population-based multi-center study.
BACKGROUND
A reference interval (RI) for the circulating concentration of anti-dsDNA antibody is essential for clinicians to interpret laboratory results and make clinical decisions. Therefore, we aimed to establish the RI for anti-dsDNA antibody in the Chinese Han population.


METHODS
This study was designed and carried out in accordance with guideline C28-A3, which is proposed by the International Federation of Clinical Chemistry and the Clinical and Laboratory Standards Institute. A total of 2,880 apparently healthy individuals were enrolled using a posteriori sampling. These individuals were recruited from four hospitals, representing the Han populations of north, south, east, and west China. Serum anti-dsDNA antibody levels were measured using the three analytical systems AESKU, EUROIMMUNE, and INOVA, which are the most commonly used systems in China. Individuals were stratified by gender, age, and region, and the RIs were obtained by nonparametric methods.


RESULTS
Gender-specific RIs for serum anti-dsDNA antibody in the Chinese Han population were established.


CONCLUSIONS
This is the first exploration of the RI for anti-dsDNA antibody in the Chinese Han population. We have established gender-specific RIs for each assay method commonly used in China.
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.|Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
Chuiwen
C
Deng
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.|Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
Shulan
S
Zhang
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.|Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
Chaojun
C
Hu
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.|Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
Ping
P
Li
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.|Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
Ziyan
Z
Wu
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.|Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
Si
S
Chen
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.|Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
Jing
J
Li
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.|Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
Liubing
L
Li
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.|Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
Fengchun
F
Zhang
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.|Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
Yongzhe
Y
Li
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000974:Antibodies, Antinuclear / Q000097:blood*; D044466:Asian People; D002681:China; D005006:Ethnicity; D005260:Female; D064368:Healthy Volunteers; D006801:Humans; D008297:Male; D008875:Middle Aged; D012016:Reference Values; D055815:Young Adult
D000974:Antibodies, Antinuclear